0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Facial Injectors Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-3Z7253
Home | Market Reports | Shopping| Consumer Resources
Global Facial Injectors Market Insights and Forecast to 2028
BUY CHAPTERS

Global Facial Injectors Market Research Report 2025

Code: QYRE-Auto-3Z7253
Report
August 2025
Pages:112
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Facial Injectors Market Size

The global market for Facial Injectors was valued at US$ 5558 million in the year 2024 and is projected to reach a revised size of US$ 9619 million by 2031, growing at a CAGR of 8.3% during the forecast period.

Facial Injectors Market

Facial Injectors Market

Facial injectors are used to inject the facial filler products, such as collagen, calcium hydroxyl apatite, and hyaluronic acid, to rejuvenate facial skin by eliminating or reducing wrinkles, enhancing lips, raising scar depressions, and substituting soft-tissue volume loss.
The rising aesthetic consciousness and the number of cosmetic procedures, the introduction of cost-effective facial injectables, and the aging population are some of the major factors propelling the market’s growth. The cosmetics industry has witnessed a boom over the past decade. In particular, there has been an increase in the total number of non-surgical procedures, such as injections of wrinkle relaxers and dermal fillers, due to the surge in aesthetic appeal and availability of highly advanced aesthetic procedures. This trend is primarily due to the advantages of technology, such as low recovery times, a lower risk of infection, no blood loss, and an overall reduction in procedural costs.
In addition, there is a consistent rise in the geriatric population, which helps boost the market"s growth. For instance, according to the 2021 WHO report, by 2030, 1 out of every 6 people across the globe will be 60 years of age or older. The number of people aged 60 and up is expected to rise from 1 billion in 2020 to 1.4 billion by 2050. By 2050, the global population of people aged 60 and above will reach 2.1 billion. Between 2020 and 2050, the number of people aged 80 and above is expected to triple, reaching 426.0 million. Since the geriatric population is the major target group for cosmetic procedures, increasing the geriatric population is likely to boost the market"s growth over the forecast period.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Facial Injectors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Facial Injectors.
The Facial Injectors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Facial Injectors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Facial Injectors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Facial Injectors Market Report

Report Metric Details
Report Name Facial Injectors Market
Accounted market size in year US$ 5558 million
Forecasted market size in 2031 US$ 9619 million
CAGR 8.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Hyaluronic Acid
  • Collagen
  • CaHA
  • PMMA
  • Others
Segment by Application
  • Specialist and Dermatology Clinic
  • Hospitals and Clinics
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Allergan, Galderma, LG Life Sciences, Merz, Medytox, HUGEL, Croma-Pharma GmbH, Beijing IMEIK, Bloomage BioTechnology, Elravie (Humedix), Cleviel (Pharma Research Products), Haohai Biological Technology, Q.O.Fill (JW Pharmaceutical), Teoxane, Sinclair, Suneva Medical, Prollenium, S&V Technologies GMBH, Luminera, Matex-Lab, Caregen, CG Bio, BioPlus, SciVision Biotech, Jingjia Medical Technology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Facial Injectors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Facial Injectors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Facial Injectors Market growing?

Ans: The Facial Injectors Market witnessing a CAGR of 8.3% during the forecast period 2025-2031.

What is the Facial Injectors Market size in 2031?

Ans: The Facial Injectors Market size in 2031 will be US$ 9619 million.

Who are the main players in the Facial Injectors Market report?

Ans: The main players in the Facial Injectors Market are Allergan, Galderma, LG Life Sciences, Merz, Medytox, HUGEL, Croma-Pharma GmbH, Beijing IMEIK, Bloomage BioTechnology, Elravie (Humedix), Cleviel (Pharma Research Products), Haohai Biological Technology, Q.O.Fill (JW Pharmaceutical), Teoxane, Sinclair, Suneva Medical, Prollenium, S&V Technologies GMBH, Luminera, Matex-Lab, Caregen, CG Bio, BioPlus, SciVision Biotech, Jingjia Medical Technology

What are the Application segmentation covered in the Facial Injectors Market report?

Ans: The Applications covered in the Facial Injectors Market report are Specialist and Dermatology Clinic, Hospitals and Clinics, Others

What are the Type segmentation covered in the Facial Injectors Market report?

Ans: The Types covered in the Facial Injectors Market report are Hyaluronic Acid, Collagen, CaHA, PMMA, Others

Recommended Reports

Injectable Fillers

Facial Anti-aging Devices

Regenerative and Injectable Products

1 Facial Injectors Market Overview
1.1 Product Definition
1.2 Facial Injectors by Type
1.2.1 Global Facial Injectors Market Value Comparison by Type (2024 VS 2031)
1.2.2 Hyaluronic Acid
1.2.3 Collagen
1.2.4 CaHA
1.2.5 PMMA
1.2.6 Others
1.3 Facial Injectors by Application
1.3.1 Global Facial Injectors Market Value by Application (2024 VS 2031)
1.3.2 Specialist and Dermatology Clinic
1.3.3 Hospitals and Clinics
1.3.4 Others
1.4 Global Facial Injectors Market Size Estimates and Forecasts
1.4.1 Global Facial Injectors Revenue 2020-2031
1.4.2 Global Facial Injectors Sales 2020-2031
1.4.3 Global Facial Injectors Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Facial Injectors Market Competition by Manufacturers
2.1 Global Facial Injectors Sales Market Share by Manufacturers (2020-2025)
2.2 Global Facial Injectors Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Facial Injectors Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Facial Injectors, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Facial Injectors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Facial Injectors, Product Type & Application
2.7 Global Key Manufacturers of Facial Injectors, Date of Enter into This Industry
2.8 Global Facial Injectors Market Competitive Situation and Trends
2.8.1 Global Facial Injectors Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Facial Injectors Players Market Share by Revenue
2.8.3 Global Facial Injectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Facial Injectors Market Scenario by Region
3.1 Global Facial Injectors Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Facial Injectors Sales by Region: 2020-2031
3.2.1 Global Facial Injectors Sales by Region: 2020-2025
3.2.2 Global Facial Injectors Sales by Region: 2026-2031
3.3 Global Facial Injectors Revenue by Region: 2020-2031
3.3.1 Global Facial Injectors Revenue by Region: 2020-2025
3.3.2 Global Facial Injectors Revenue by Region: 2026-2031
3.4 North America Facial Injectors Market Facts & Figures by Country
3.4.1 North America Facial Injectors Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Facial Injectors Sales by Country (2020-2031)
3.4.3 North America Facial Injectors Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Facial Injectors Market Facts & Figures by Country
3.5.1 Europe Facial Injectors Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Facial Injectors Sales by Country (2020-2031)
3.5.3 Europe Facial Injectors Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Facial Injectors Market Facts & Figures by Region
3.6.1 Asia Pacific Facial Injectors Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Facial Injectors Sales by Region (2020-2031)
3.6.3 Asia Pacific Facial Injectors Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Facial Injectors Market Facts & Figures by Country
3.7.1 Latin America Facial Injectors Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Facial Injectors Sales by Country (2020-2031)
3.7.3 Latin America Facial Injectors Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Facial Injectors Market Facts & Figures by Country
3.8.1 Middle East and Africa Facial Injectors Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Facial Injectors Sales by Country (2020-2031)
3.8.3 Middle East and Africa Facial Injectors Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Facial Injectors Sales by Type (2020-2031)
4.1.1 Global Facial Injectors Sales by Type (2020-2025)
4.1.2 Global Facial Injectors Sales by Type (2026-2031)
4.1.3 Global Facial Injectors Sales Market Share by Type (2020-2031)
4.2 Global Facial Injectors Revenue by Type (2020-2031)
4.2.1 Global Facial Injectors Revenue by Type (2020-2025)
4.2.2 Global Facial Injectors Revenue by Type (2026-2031)
4.2.3 Global Facial Injectors Revenue Market Share by Type (2020-2031)
4.3 Global Facial Injectors Price by Type (2020-2031)
5 Segment by Application
5.1 Global Facial Injectors Sales by Application (2020-2031)
5.1.1 Global Facial Injectors Sales by Application (2020-2025)
5.1.2 Global Facial Injectors Sales by Application (2026-2031)
5.1.3 Global Facial Injectors Sales Market Share by Application (2020-2031)
5.2 Global Facial Injectors Revenue by Application (2020-2031)
5.2.1 Global Facial Injectors Revenue by Application (2020-2025)
5.2.2 Global Facial Injectors Revenue by Application (2026-2031)
5.2.3 Global Facial Injectors Revenue Market Share by Application (2020-2031)
5.3 Global Facial Injectors Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Company Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Facial Injectors Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Allergan Facial Injectors Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Galderma
6.2.1 Galderma Company Information
6.2.2 Galderma Description and Business Overview
6.2.3 Galderma Facial Injectors Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Galderma Facial Injectors Product Portfolio
6.2.5 Galderma Recent Developments/Updates
6.3 LG Life Sciences
6.3.1 LG Life Sciences Company Information
6.3.2 LG Life Sciences Description and Business Overview
6.3.3 LG Life Sciences Facial Injectors Sales, Revenue and Gross Margin (2020-2025)
6.3.4 LG Life Sciences Facial Injectors Product Portfolio
6.3.5 LG Life Sciences Recent Developments/Updates
6.4 Merz
6.4.1 Merz Company Information
6.4.2 Merz Description and Business Overview
6.4.3 Merz Facial Injectors Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Merz Facial Injectors Product Portfolio
6.4.5 Merz Recent Developments/Updates
6.5 Medytox
6.5.1 Medytox Company Information
6.5.2 Medytox Description and Business Overview
6.5.3 Medytox Facial Injectors Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Medytox Facial Injectors Product Portfolio
6.5.5 Medytox Recent Developments/Updates
6.6 HUGEL
6.6.1 HUGEL Company Information
6.6.2 HUGEL Description and Business Overview
6.6.3 HUGEL Facial Injectors Sales, Revenue and Gross Margin (2020-2025)
6.6.4 HUGEL Facial Injectors Product Portfolio
6.6.5 HUGEL Recent Developments/Updates
6.7 Croma-Pharma GmbH
6.7.1 Croma-Pharma GmbH Company Information
6.7.2 Croma-Pharma GmbH Description and Business Overview
6.7.3 Croma-Pharma GmbH Facial Injectors Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Croma-Pharma GmbH Facial Injectors Product Portfolio
6.7.5 Croma-Pharma GmbH Recent Developments/Updates
6.8 Beijing IMEIK
6.8.1 Beijing IMEIK Company Information
6.8.2 Beijing IMEIK Description and Business Overview
6.8.3 Beijing IMEIK Facial Injectors Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Beijing IMEIK Facial Injectors Product Portfolio
6.8.5 Beijing IMEIK Recent Developments/Updates
6.9 Bloomage BioTechnology
6.9.1 Bloomage BioTechnology Company Information
6.9.2 Bloomage BioTechnology Description and Business Overview
6.9.3 Bloomage BioTechnology Facial Injectors Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Bloomage BioTechnology Facial Injectors Product Portfolio
6.9.5 Bloomage BioTechnology Recent Developments/Updates
6.10 Elravie (Humedix)
6.10.1 Elravie (Humedix) Company Information
6.10.2 Elravie (Humedix) Description and Business Overview
6.10.3 Elravie (Humedix) Facial Injectors Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Elravie (Humedix) Facial Injectors Product Portfolio
6.10.5 Elravie (Humedix) Recent Developments/Updates
6.11 Cleviel (Pharma Research Products)
6.11.1 Cleviel (Pharma Research Products) Company Information
6.11.2 Cleviel (Pharma Research Products) Description and Business Overview
6.11.3 Cleviel (Pharma Research Products) Facial Injectors Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Cleviel (Pharma Research Products) Facial Injectors Product Portfolio
6.11.5 Cleviel (Pharma Research Products) Recent Developments/Updates
6.12 Haohai Biological Technology
6.12.1 Haohai Biological Technology Company Information
6.12.2 Haohai Biological Technology Description and Business Overview
6.12.3 Haohai Biological Technology Facial Injectors Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Haohai Biological Technology Facial Injectors Product Portfolio
6.12.5 Haohai Biological Technology Recent Developments/Updates
6.13 Q.O.Fill (JW Pharmaceutical)
6.13.1 Q.O.Fill (JW Pharmaceutical) Company Information
6.13.2 Q.O.Fill (JW Pharmaceutical) Description and Business Overview
6.13.3 Q.O.Fill (JW Pharmaceutical) Facial Injectors Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Q.O.Fill (JW Pharmaceutical) Facial Injectors Product Portfolio
6.13.5 Q.O.Fill (JW Pharmaceutical) Recent Developments/Updates
6.14 Teoxane
6.14.1 Teoxane Company Information
6.14.2 Teoxane Description and Business Overview
6.14.3 Teoxane Facial Injectors Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Teoxane Facial Injectors Product Portfolio
6.14.5 Teoxane Recent Developments/Updates
6.15 Sinclair
6.15.1 Sinclair Company Information
6.15.2 Sinclair Description and Business Overview
6.15.3 Sinclair Facial Injectors Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Sinclair Facial Injectors Product Portfolio
6.15.5 Sinclair Recent Developments/Updates
6.16 Suneva Medical
6.16.1 Suneva Medical Company Information
6.16.2 Suneva Medical Description and Business Overview
6.16.3 Suneva Medical Facial Injectors Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Suneva Medical Facial Injectors Product Portfolio
6.16.5 Suneva Medical Recent Developments/Updates
6.17 Prollenium
6.17.1 Prollenium Company Information
6.17.2 Prollenium Description and Business Overview
6.17.3 Prollenium Facial Injectors Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Prollenium Facial Injectors Product Portfolio
6.17.5 Prollenium Recent Developments/Updates
6.18 S&V Technologies GMBH
6.18.1 S&V Technologies GMBH Company Information
6.18.2 S&V Technologies GMBH Description and Business Overview
6.18.3 S&V Technologies GMBH Facial Injectors Sales, Revenue and Gross Margin (2020-2025)
6.18.4 S&V Technologies GMBH Facial Injectors Product Portfolio
6.18.5 S&V Technologies GMBH Recent Developments/Updates
6.19 Luminera
6.19.1 Luminera Company Information
6.19.2 Luminera Description and Business Overview
6.19.3 Luminera Facial Injectors Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Luminera Facial Injectors Product Portfolio
6.19.5 Luminera Recent Developments/Updates
6.20 Matex-Lab
6.20.1 Matex-Lab Company Information
6.20.2 Matex-Lab Description and Business Overview
6.20.3 Matex-Lab Facial Injectors Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Matex-Lab Facial Injectors Product Portfolio
6.20.5 Matex-Lab Recent Developments/Updates
6.21 Caregen
6.21.1 Caregen Company Information
6.21.2 Caregen Description and Business Overview
6.21.3 Caregen Facial Injectors Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Caregen Facial Injectors Product Portfolio
6.21.5 Caregen Recent Developments/Updates
6.22 CG Bio
6.22.1 CG Bio Company Information
6.22.2 CG Bio Description and Business Overview
6.22.3 CG Bio Facial Injectors Sales, Revenue and Gross Margin (2020-2025)
6.22.4 CG Bio Facial Injectors Product Portfolio
6.22.5 CG Bio Recent Developments/Updates
6.23 BioPlus
6.23.1 BioPlus Company Information
6.23.2 BioPlus Description and Business Overview
6.23.3 BioPlus Facial Injectors Sales, Revenue and Gross Margin (2020-2025)
6.23.4 BioPlus Facial Injectors Product Portfolio
6.23.5 BioPlus Recent Developments/Updates
6.24 SciVision Biotech
6.24.1 SciVision Biotech Company Information
6.24.2 SciVision Biotech Description and Business Overview
6.24.3 SciVision Biotech Facial Injectors Sales, Revenue and Gross Margin (2020-2025)
6.24.4 SciVision Biotech Facial Injectors Product Portfolio
6.24.5 SciVision Biotech Recent Developments/Updates
6.25 Jingjia Medical Technology
6.25.1 Jingjia Medical Technology Company Information
6.25.2 Jingjia Medical Technology Description and Business Overview
6.25.3 Jingjia Medical Technology Facial Injectors Sales, Revenue and Gross Margin (2020-2025)
6.25.4 Jingjia Medical Technology Facial Injectors Product Portfolio
6.25.5 Jingjia Medical Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Facial Injectors Industry Chain Analysis
7.2 Facial Injectors Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Facial Injectors Production Mode & Process Analysis
7.4 Facial Injectors Sales and Marketing
7.4.1 Facial Injectors Sales Channels
7.4.2 Facial Injectors Distributors
7.5 Facial Injectors Customer Analysis
8 Facial Injectors Market Dynamics
8.1 Facial Injectors Industry Trends
8.2 Facial Injectors Market Drivers
8.3 Facial Injectors Market Challenges
8.4 Facial Injectors Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Facial Injectors Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Facial Injectors Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Facial Injectors Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Facial Injectors Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Facial Injectors Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Facial Injectors Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Facial Injectors Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Facial Injectors Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Facial Injectors, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Facial Injectors, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Facial Injectors, Product Type & Application
 Table 12. Global Key Manufacturers of Facial Injectors, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Facial Injectors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Facial Injectors as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Facial Injectors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Facial Injectors Sales by Region (2020-2025) & (K Units)
 Table 18. Global Facial Injectors Sales Market Share by Region (2020-2025)
 Table 19. Global Facial Injectors Sales by Region (2026-2031) & (K Units)
 Table 20. Global Facial Injectors Sales Market Share by Region (2026-2031)
 Table 21. Global Facial Injectors Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Facial Injectors Revenue Market Share by Region (2020-2025)
 Table 23. Global Facial Injectors Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Facial Injectors Revenue Market Share by Region (2026-2031)
 Table 25. North America Facial Injectors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Facial Injectors Sales by Country (2020-2025) & (K Units)
 Table 27. North America Facial Injectors Sales by Country (2026-2031) & (K Units)
 Table 28. North America Facial Injectors Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Facial Injectors Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Facial Injectors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Facial Injectors Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Facial Injectors Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Facial Injectors Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Facial Injectors Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Facial Injectors Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Facial Injectors Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Facial Injectors Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Facial Injectors Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Facial Injectors Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Facial Injectors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Facial Injectors Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Facial Injectors Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Facial Injectors Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Facial Injectors Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Facial Injectors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Facial Injectors Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Facial Injectors Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Facial Injectors Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Facial Injectors Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Facial Injectors Sales (K Units) by Type (2020-2025)
 Table 51. Global Facial Injectors Sales (K Units) by Type (2026-2031)
 Table 52. Global Facial Injectors Sales Market Share by Type (2020-2025)
 Table 53. Global Facial Injectors Sales Market Share by Type (2026-2031)
 Table 54. Global Facial Injectors Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Facial Injectors Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Facial Injectors Revenue Market Share by Type (2020-2025)
 Table 57. Global Facial Injectors Revenue Market Share by Type (2026-2031)
 Table 58. Global Facial Injectors Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Facial Injectors Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Facial Injectors Sales (K Units) by Application (2020-2025)
 Table 61. Global Facial Injectors Sales (K Units) by Application (2026-2031)
 Table 62. Global Facial Injectors Sales Market Share by Application (2020-2025)
 Table 63. Global Facial Injectors Sales Market Share by Application (2026-2031)
 Table 64. Global Facial Injectors Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Facial Injectors Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Facial Injectors Revenue Market Share by Application (2020-2025)
 Table 67. Global Facial Injectors Revenue Market Share by Application (2026-2031)
 Table 68. Global Facial Injectors Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Facial Injectors Price (USD/Unit) by Application (2026-2031)
 Table 70. Allergan Company Information
 Table 71. Allergan Description and Business Overview
 Table 72. Allergan Facial Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Allergan Facial Injectors Product
 Table 74. Allergan Recent Developments/Updates
 Table 75. Galderma Company Information
 Table 76. Galderma Description and Business Overview
 Table 77. Galderma Facial Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Galderma Facial Injectors Product
 Table 79. Galderma Recent Developments/Updates
 Table 80. LG Life Sciences Company Information
 Table 81. LG Life Sciences Description and Business Overview
 Table 82. LG Life Sciences Facial Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. LG Life Sciences Facial Injectors Product
 Table 84. LG Life Sciences Recent Developments/Updates
 Table 85. Merz Company Information
 Table 86. Merz Description and Business Overview
 Table 87. Merz Facial Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Merz Facial Injectors Product
 Table 89. Merz Recent Developments/Updates
 Table 90. Medytox Company Information
 Table 91. Medytox Description and Business Overview
 Table 92. Medytox Facial Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Medytox Facial Injectors Product
 Table 94. Medytox Recent Developments/Updates
 Table 95. HUGEL Company Information
 Table 96. HUGEL Description and Business Overview
 Table 97. HUGEL Facial Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. HUGEL Facial Injectors Product
 Table 99. HUGEL Recent Developments/Updates
 Table 100. Croma-Pharma GmbH Company Information
 Table 101. Croma-Pharma GmbH Description and Business Overview
 Table 102. Croma-Pharma GmbH Facial Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Croma-Pharma GmbH Facial Injectors Product
 Table 104. Croma-Pharma GmbH Recent Developments/Updates
 Table 105. Beijing IMEIK Company Information
 Table 106. Beijing IMEIK Description and Business Overview
 Table 107. Beijing IMEIK Facial Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Beijing IMEIK Facial Injectors Product
 Table 109. Beijing IMEIK Recent Developments/Updates
 Table 110. Bloomage BioTechnology Company Information
 Table 111. Bloomage BioTechnology Description and Business Overview
 Table 112. Bloomage BioTechnology Facial Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Bloomage BioTechnology Facial Injectors Product
 Table 114. Bloomage BioTechnology Recent Developments/Updates
 Table 115. Elravie (Humedix) Company Information
 Table 116. Elravie (Humedix) Description and Business Overview
 Table 117. Elravie (Humedix) Facial Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Elravie (Humedix) Facial Injectors Product
 Table 119. Elravie (Humedix) Recent Developments/Updates
 Table 120. Cleviel (Pharma Research Products) Company Information
 Table 121. Cleviel (Pharma Research Products) Description and Business Overview
 Table 122. Cleviel (Pharma Research Products) Facial Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Cleviel (Pharma Research Products) Facial Injectors Product
 Table 124. Cleviel (Pharma Research Products) Recent Developments/Updates
 Table 125. Haohai Biological Technology Company Information
 Table 126. Haohai Biological Technology Description and Business Overview
 Table 127. Haohai Biological Technology Facial Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. Haohai Biological Technology Facial Injectors Product
 Table 129. Haohai Biological Technology Recent Developments/Updates
 Table 130. Q.O.Fill (JW Pharmaceutical) Company Information
 Table 131. Q.O.Fill (JW Pharmaceutical) Description and Business Overview
 Table 132. Q.O.Fill (JW Pharmaceutical) Facial Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 133. Q.O.Fill (JW Pharmaceutical) Facial Injectors Product
 Table 134. Q.O.Fill (JW Pharmaceutical) Recent Developments/Updates
 Table 135. Teoxane Company Information
 Table 136. Teoxane Description and Business Overview
 Table 137. Teoxane Facial Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 138. Teoxane Facial Injectors Product
 Table 139. Teoxane Recent Developments/Updates
 Table 140. Sinclair Company Information
 Table 141. Sinclair Description and Business Overview
 Table 142. Sinclair Facial Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 143. Sinclair Facial Injectors Product
 Table 144. Sinclair Recent Developments/Updates
 Table 145. Suneva Medical Company Information
 Table 146. Suneva Medical Description and Business Overview
 Table 147. Suneva Medical Facial Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 148. Suneva Medical Facial Injectors Product
 Table 149. Suneva Medical Recent Developments/Updates
 Table 150. Prollenium Company Information
 Table 151. Prollenium Description and Business Overview
 Table 152. Prollenium Facial Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 153. Prollenium Facial Injectors Product
 Table 154. Prollenium Recent Developments/Updates
 Table 155. S&V Technologies GMBH Company Information
 Table 156. S&V Technologies GMBH Description and Business Overview
 Table 157. S&V Technologies GMBH Facial Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 158. S&V Technologies GMBH Facial Injectors Product
 Table 159. S&V Technologies GMBH Recent Developments/Updates
 Table 160. Luminera Company Information
 Table 161. Luminera Description and Business Overview
 Table 162. Luminera Facial Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 163. Luminera Facial Injectors Product
 Table 164. Luminera Recent Developments/Updates
 Table 165. Matex-Lab Company Information
 Table 166. Matex-Lab Description and Business Overview
 Table 167. Matex-Lab Facial Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 168. Matex-Lab Facial Injectors Product
 Table 169. Matex-Lab Recent Developments/Updates
 Table 170. Caregen Company Information
 Table 171. Caregen Description and Business Overview
 Table 172. Caregen Facial Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 173. Caregen Facial Injectors Product
 Table 174. Caregen Recent Developments/Updates
 Table 175. CG Bio Company Information
 Table 176. CG Bio Description and Business Overview
 Table 177. CG Bio Facial Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 178. CG Bio Facial Injectors Product
 Table 179. CG Bio Recent Developments/Updates
 Table 180. BioPlus Company Information
 Table 181. BioPlus Description and Business Overview
 Table 182. BioPlus Facial Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 183. BioPlus Facial Injectors Product
 Table 184. BioPlus Recent Developments/Updates
 Table 185. SciVision Biotech Company Information
 Table 186. SciVision Biotech Description and Business Overview
 Table 187. SciVision Biotech Facial Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 188. SciVision Biotech Facial Injectors Product
 Table 189. SciVision Biotech Recent Developments/Updates
 Table 190. Jingjia Medical Technology Company Information
 Table 191. Jingjia Medical Technology Description and Business Overview
 Table 192. Jingjia Medical Technology Facial Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 193. Jingjia Medical Technology Facial Injectors Product
 Table 194. Jingjia Medical Technology Recent Developments/Updates
 Table 195. Key Raw Materials Lists
 Table 196. Raw Materials Key Suppliers Lists
 Table 197. Facial Injectors Distributors List
 Table 198. Facial Injectors Customers List
 Table 199. Facial Injectors Market Trends
 Table 200. Facial Injectors Market Drivers
 Table 201. Facial Injectors Market Challenges
 Table 202. Facial Injectors Market Restraints
 Table 203. Research Programs/Design for This Report
 Table 204. Key Data Information from Secondary Sources
 Table 205. Key Data Information from Primary Sources
 Table 206. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Facial Injectors
 Figure 2. Global Facial Injectors Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Facial Injectors Market Share by Type: 2024 & 2031
 Figure 4. Hyaluronic Acid Product Picture
 Figure 5. Collagen Product Picture
 Figure 6. CaHA Product Picture
 Figure 7. PMMA Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Facial Injectors Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Facial Injectors Market Share by Application: 2024 & 2031
 Figure 11. Specialist and Dermatology Clinic
 Figure 12. Hospitals and Clinics
 Figure 13. Others
 Figure 14. Global Facial Injectors Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Facial Injectors Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Facial Injectors Sales (2020-2031) & (K Units)
 Figure 17. Global Facial Injectors Average Price (USD/Unit) & (2020-2031)
 Figure 18. Facial Injectors Report Years Considered
 Figure 19. Facial Injectors Sales Share by Manufacturers in 2024
 Figure 20. Global Facial Injectors Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Facial Injectors Players: Market Share by Revenue in Facial Injectors in 2024
 Figure 22. Facial Injectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Facial Injectors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Facial Injectors Sales Market Share by Country (2020-2031)
 Figure 25. North America Facial Injectors Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Facial Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Facial Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Facial Injectors Sales Market Share by Country (2020-2031)
 Figure 29. Europe Facial Injectors Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Facial Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Facial Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Facial Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Facial Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Facial Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Facial Injectors Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Facial Injectors Revenue Market Share by Region (2020-2031)
 Figure 37. China Facial Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Facial Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Facial Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Facial Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Facial Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Facial Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Facial Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Facial Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Facial Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Facial Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Facial Injectors Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Facial Injectors Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Facial Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Facial Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Facial Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Facial Injectors Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Facial Injectors Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Facial Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Facial Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. U.A.E Facial Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Facial Injectors by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Facial Injectors by Type (2020-2031)
 Figure 59. Global Facial Injectors Price (USD/Unit) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Facial Injectors by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Facial Injectors by Application (2020-2031)
 Figure 62. Global Facial Injectors Price (USD/Unit) by Application (2020-2031)
 Figure 63. Facial Injectors Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS